Report cover image

Oncology Biomarkers: Global Markets

Publisher BCC Research
Published Jun 15, 2023
Length 186 Pages
SKU # WA18013921

Description

Oncology Biomarkers: Global Markets



Report Scope:

This study provides a comprehensive analysis of oncology biomarkers on a global basis. It aims to offer a range of information, from detailed market analyses within cancer types to overall industry trends, to quantify and qualify the market for products and services in the oncology biomarkers segment. Current and projected market forecasts during the forecast period (2023 to 2028) are discussed. Figures for 2023 are estimated, except where actual results have been reported.

This report includes forecasts by biomarker type, cancer type, application, and region from 2023 through 2028. The report also includes an analysis of leading and emerging competitors in the current worldwide oncology biomarkers market. The competitive environment is examined with a particular focus on how new products and technologies influence the current standard of care.

Report Includes:

21 data tables and 60 additional tables

An in-depth analysis of the global oncology biomarkers market

Analyses of global market trends, with data from 2020, 2021, 2022, and projections of compound annual growth rates (CAGRs) through 2028

Characterization and quantification of biomarkers market by type, profiling technology, application, cancer type, and region

Discussion on market drivers, challenges and key market strategies and trends

Information on emerging products and technologies, new analytical platforms, novel immunoassays, and bioinformatics tools and discussion on the use of biomarkers in cancer drug development

Profiles of the competitive landscape with an overview of competitor growth strategies and opportunities

Company profiles of major players within the industry, including Abbott, F. Hoffmann-La Roche Ltd., Merck KGaA, Siemens Healthineers AG, and Thermo Fisher Scientific Inc.

Table of Contents

186 Pages
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology and Information Sources
Geographic Breakdown
Analyst’s Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market Outlook
Chapter 4 Market and Technology Background
Overview of Biomarkers
Classification of Biomarkers
Types of Biomarkers
Biomarker Discovery, Verification and Validation
Overview of Cancer
Cancer/Oncology Biomarkers
Oncology Biomarkers Testing Methods
Oncology Biomarkers Testing Types
Biomarker Test Development and Marketing
Chapter 5 Market Dynamics
Drivers
Rising Incidence of Cancer
Increasing Use of Biomarkers in Drug Discovery and Development
Developments in Analytical Technologies and Assay Methods
Increased Availability and Ease of Biomarker Testing
Support from Regulatory Agencies
Barriers
Inadequate Patient Access to and Insurance Coverage of Biomarker Testing
Technical Errors and Delayed Test Results
Low Provider and Patient Awareness
Suboptimal Tissue Procurement and Triaging
Shortages of Laboratories and Personnel
Chapter 6 Market Breakdown by Biomarker Type
Protein Biomarkers
Protein Biomarkers Profiling Technologies
Genomic Biomarker
Genomic Biomarkers Profiling Technologies
Other Biomarkers
Metabolomic Biomarkers
Cellular Biomarkers
Global Market for Oncology Biomarkers, by Biomarker Type
Protein Biomarkers
Genomic Biomarkers
Other Biomarkers
Chapter 7 Market Breakdown by Application
Life Science Research
Risk Assessment and Screening
Diagnostics
Prognostics
Therapeutic Selection and Clinical Trials
Monitoring
Response Monitoring
Recurrence/Minimal Residual Disease (MRD) Monitoring
Global Market for Oncology Biomarkers by Application
Life Science Research
Risk Assessment and Screening
Diagnostics
Prognostics
Therapeutic Selection and Clinical Trials
Monitoring
Chapter 8 Market Breakdown by Cancer Type
Market Overview
Breast Cancer
Lung Cancer
Colorectal Cancer (CRC)
Prostate Cancer
Bladder Cancer
Melanoma
Leukemia
Others
Ovarian Cancer
Liver Cancer
Thyroid Cancer
Cervical Cancer
Kidney Cancer
Endometrial Cancer
Global Market for Oncology Biomarkers by Cancer Type
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Bladder Cancer
Melanoma
Leukemia
Other Cancers
Chapter 9 Market Breakdown by Region
Global Market for Oncology Biomarkers by Region
North America
Market Revenue by Application
Market Revenue by Country
Europe
Market Revenue by Application
Market Revenue by Country
Asia-Pacific
Market Revenue by Application
Market Revenue by Country
Rest of World
Market Revenue by Application
Chapter 10 Impact of COVID-19
Overview
Implications on Cancer Diagnosis
Implications on Cancer Treatment
Impact on Oncology Biomarkers Market
Chapter 11 Emerging Trends and Technologies in the Market
Emerging Technologies and Trends in the Market
Liquid Biopsy
Circulating Free Nucleic Acids
Circulating Cell-Free DNA (CfDNA)
“Organ Agnostic” Biomarker Testing
PD-L1
Homologous Recombination Deficiency (HRD)
Blood Test for Early-Stage Cancer Detection
Chapter 12 Competitive Landscape
Overview
Mergers and Acquisitions
SWOT Analysis for Global Oncology Biomarker Market
Porter’s Five Forces Analysis of Global Oncology Biomarker Market
Chapter 13 Company Profiles
AGENDIA INC.
ABBOTT
AGILENT TECHNOLOGIES INC.
BIOCARTIS NV
BIOMERIEUX S.A.
BIO-RAD LABORATORIES INC.
BECTON, DICKINSON & CO.
EXACT SCIENCES CORP.
F. HOFFMANN-LA ROCHE AG
GUARDANT HEALTH INC.
HOLOGIC INC.
ILLUMINA INC.
LEICA BIOSYSTEMS
MERCK KGAA
MYRIAD GENETICS INC.
QIAGEN N.V.
SIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.
VERACYTE INC.
Chapter 14 Appendix: Acronyms

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us